NEW HAVEN, Conn., Nov. 12, 2025 — Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical […]
Year: 2025
V2X, INC. ANNOUNCES SALE OF 2.25 MILLION SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE
RESTON, Va., Nov. 12, 2025 — V2X, Inc. (NYSE:VVX) (“V2X”), a leading provider of […]
Lucid Group, Inc. Prices $875,000,000 Convertible Senior Notes Offering
NEWARK, Calif., Nov. 12, 2025 — Lucid Group, Inc. (Nasdaq: LCID) today announced the […]
INTERNATIONAL AIRPORT FINANCE, S.A. ANNOUNCES THE SETTLEMENT DATE OF THE CONSENT SOLICITATION RELATED TO THE 12.000% SENIOR SECURED NOTES DUE 2033
(CUSIP Nos. 45900T AA0 / E6R69L AA2;ISIN Nos. US45900TAA07 / USE6R69LAA27) MADRID, Spain, Nov. 11, […]
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
HOUSTON, Nov. 11, 2025 — Salarius Pharmaceuticals, Inc. (“Salarius” or the “Company”) (NASDAQ: SLRX) […]
INOVIO Announces Pricing of $25 Million Public Offering
PLYMOUTH MEETING, Pa., Nov. 11, 2025 — INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company […]
CleanSpark, Inc. Announces Upsize and Pricing of $1.15 Billion Convertible Notes Offering
LAS VEGAS, Nov. 10, 2025 — CleanSpark, Inc. (Nasdaq: CLSK), America’s Bitcoin Miner® (“CleanSpark” […]
CleanSpark, Inc. Announces Proposed Private Offering of $1 Billion of Convertible Notes
LAS VEGAS, Nov. 10, 2025 — CleanSpark, Inc. (Nasdaq: CLSK), America’s Bitcoin Miner® (“CleanSpark” or […]
Trilogy Metals Enters Into At-The-Market Equity Distribution Agreement
VANCOUVER, BC, Nov. 7, 2025 – Trilogy Metals Inc. (NYSE American:TMQ) (TSX: TMQ) (“Trilogy […]